Utah Medical Products, Inc.
General ticker "UTMD" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $202.8M (TTM average)
Utah Medical Products, Inc. follows the US Stock Market performance with the rate: 43.6%.
Estimated limits based on current volatility of 2.2%: low 70.69$, high 73.82$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-06-17, amount 0.31$ (Y1.67%)
- Total employees count: 140 (-9.7%) as of 2025
- Top business risk factors: Regulatory and compliance, GPO restrictions, Product liability claims, Supply chain disruptions, Currency fluctuations
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [50.22$, 68.72$]
- 2026-12-31 to 2027-12-31 estimated range: [53.81$, 72.74$]
Financial Metrics affecting the UTMD estimates:
- Positive: with PPE of 16.3 at the end of fiscal year the price was neutral
- Positive: 22.58 < Operating profit margin, % of 29.60
- Positive: 6.77 < Operating cash flow per share per price, % of 8.02
- Positive: Shareholder equity ratio, % of 97.33 > 81.92
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 1.58
Short-term UTMD quotes
Long-term UTMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $50.22MM | $40.90MM | $38.52MM |
| Operating Expenses | $33.45MM | $27.31MM | $27.12MM |
| Operating Income | $16.78MM | $13.59MM | $11.40MM |
| Non-Operating Income | $3.31MM | $3.21MM | $2.71MM |
| R&D Expense | $0.56MM | $0.81MM | $0.67MM |
| Income(Loss) | $20.09MM | $16.80MM | $14.11MM |
| Taxes | $3.45MM | $2.93MM | $2.82MM |
| Net Income(Loss)* | $16.64MM | $13.87MM | $11.29MM |
| Stockholders Equity | $128.31MM | $117.43MM | $119.27MM |
| Inventory | $9.58MM | $8.81MM | $7.93MM |
| Assets | $135.46MM | $122.54MM | $122.54MM |
| Operating Cash Flow | $22.28MM | $14.83MM | $14.69MM |
| Capital expenditure | $0.64MM | $0.23MM | $0.37MM |
| Investing Cash Flow | $-0.64MM | $-0.21MM | $-0.37MM |
| Financing Cash Flow | $-4.17MM | $-23.84MM | $-12.34MM |
| Earnings Per Share** | $4.57 | $3.96 | $3.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.